Transaction · 0001683168-26-006985

Turner Matthew Baker

Turner Matthew Baker, PRES, PA, reported a transaction classified as withholding at Paysign, Inc. involving 50681.000000 shares for an estimated $340576.32. Reported holdings after the transaction were 404262.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FPRES, PA
PAYSPaysign, Inc.
Filing timeSep 04
Trade dateMay 22, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$12.96
Pre-filing
1mo ago -55.1%1w ago -47.1%1d ago -47.1%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

PAYS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PAYS since 2026-09-04Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001683168-26-006985
Common Stock
Transaction date
May 22, 2026
Filed Sep 04, 2026, 10:42 PM · 105d delay
Shares
50.6k sh
$672 per share
Estimated value
-$34.0M
Computed from shares × price
Holdings after
404k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 105 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
-22score
Filing-only score

-22

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRES., PATIENT AFFORDABILITY

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The res…

  2. F2

    Represents shares of common stock sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock.

  3. F3

    Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock.

Original filing · 0001683168-26-006985
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PAYS